Treatment of cancer
作者： John Ryan
DOI:
关键词: Cancer research 、 Conjugate 、 Camptothecin derivative 、 Chemistry 、 CRLX101 、 Cancer
摘要: Provided are methods relating to compositions that include a CDP-topoisomerase inhibitor, e.g., CDP-camptothecin or camptothecin derivative conjugate, CRLX101.
google.com.ar 参考文章(48)
Jean-Marie Lehn, JL Atwood, JED Davies, DD MacNicol, F Vögtle, Comprehensive Supramolecular Chemistry ,(1996)
Wen-Yang Wu, Betty Jin, Dimeric inhibitors of influenza neuraminidase ,(2000)
David Lebwohl, Maurizio Voi, Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases ,(2003)
Mati Fridkin, Terry W. Moody, Albert Levy, Edgar Gelber, Illana Gozes, Douglas C. Brenneman, Combination therapy with vip antagonist ,(1999)
Patricia Vrignaud, Marie-Christine Bissery, Marielle Chiron-Blondel, Pascale Lejeune, Antitumour combinations containing a vegf inhibiting agent and irinotecan ,(2008)
Edwin Bernard Villhauer, N-substituted 2-cyanopyrrolidines ,(1999)
Frederick H. Hausheer, Chemoprotective methods and compositions ,(2006)
Brent R. Stockwell, Identification of genotype-selective anti-tumor agents ,(2004)
James A. Bianco, Combinatorial drug therapy using polymer drug conjugates ,(2003)
Ivan Horak, Puja Sapra, Method of treating ras associated cancer ,(2009)